MicroPort CardioFlow Medtech Corporation released an updated schedule of its board members and their roles as of 4 June 2026, detailing both director positions and committee responsibilities.

The Board now consists of nine directors: • Non-executive Directors: Mr. Chen Guoming (Chairman) and Dr. Brian Chang (Co-Chairman) • Executive Directors: Mr. Zhang Ruinian (Chief Executive Officer) and Mr. Philippe Wanstok (President) • Non-executive Director: Mr. Deng Aoyi • Independent Non-executive Directors: Mr. Jonathan H. Chou, Ms. Sun Zhixiang, Dr. Hu Bingshan and Mr. Mao Junxiang

Committee structure and leadership were also confirmed:

1. Audit Committee – Chair: Mr. Jonathan H. Chou – Members: Dr. Brian Chang, Ms. Sun Zhixiang, Dr. Hu Bingshan

2. Remuneration Committee – Chair: Ms. Sun Zhixiang – Members: Mr. Chen Guoming, Mr. Zhang Ruinian

3. Nomination Committee – Chair: Dr. Hu Bingshan – Members: Dr. Brian Chang, Mr. Philippe Wanstok, Ms. Sun Zhixiang

4. Strategy Committee – Chair: Mr. Chen Guoming – Members: Dr. Brian Chang, Mr. Zhang Ruinian, Mr. Philippe Wanstok

5. Commercialization Committee – Chair: Dr. Brian Chang – Members: Mr. Chen Guoming, Mr. Deng Aoyi, Mr. Jonathan H. Chou, Dr. Hu Bingshan, Mr. Mao Junxiang

The announcement consolidates governance responsibilities across five specialized committees, underscoring the company’s adherence to a structured oversight framework as it advances its cardiovascular medical technology portfolio.